NCT01925157 - A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) | Biotech Hunter

Enrollment

43

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

September 30, 2015

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

LY3090106 - SQ

Administered SQ.

BIOLOGICAL

LY3090106 - IV

Administered IV.

BIOLOGICAL

Placebo - SQ

Administered SQ.

Trial Locations (4)

1612

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sofia

50159

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bucharest

MD2025

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chisinau

85-168

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bydgoszcz